Albert Bourla
At a glance: Albert Bourla is CEO, Chair at Pfizer (PFE). Their latest SEC Form 4, filed Aug 12, 2026, reported a purchase of $1.0M. On file: 1 purchase line ($1.0M) and 0 sale lines ($0).
Disclosed holdings: about $11.9M of PFE stock: 429,173 shares reported on their latest Form 4 (filed Aug 12, 2026), valued at the Nov 19, 2026 close of $27.64. This counts only PFE shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
CEO, Chair at Pfizer Inc (PFE)
Purchase track record
Not enough history. Based on 1 purchase with a full 90 days of price history.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Aug 12SEC | PFEPfizer IncFirst buy | Buy | 38,000429,173 held (+10%) | $26.34 | $1.0M | +5.0% |
- Buy
CEO, Chair Albert Bourla bought $1.0M of PFE at $26.34 — first open-market purchase in our records.
Follow Albert Bourla
Get one email when Albert Bourla files a new purchase or sale. Free.
At most one email a day about Albert Bourla, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.